US Patent Issued to SHENZHEN RUIJIAN BIOTECHNOLOGY on Dec. 2 for "Long-acting low-addiction HNK derivative and preparation method therefor" (Canadian, American Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,242, issued on Dec. 2, was assigned to SHENZHEN RUIJIAN BIOTECHNOLOGY Co. LTD. (Guangdong, China).

"Long-acting low-addiction HNK derivative and preparation method therefor" was invented by Shu Peng Li (Oakville, Canada) and Qiang Zhou (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a compound having the functions of being an antidepressant, improving anxiety and post-traumatic stress syndrome, anesthetizing, easing pain, improving cognitive function, protecting the lungs, preventing or treating amyotrophic lateral sclerosis or preventing or treating complex regional pain syndrome. Compared with existi...